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Modification of the IFCC reference measurement
procedure for determination of HbA1c by HPLC-ESI-MS
Modifikation des IFCC Referenzmessverfahrens zur Bestimmung von
HbA1c mittels HPLC-ESI-MS
Abstract
The reference measurement procedure for determination of HbA1c
(glycated haemoglobin) using HPLC(high performance liquid chromato-
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graphy)-ESI(electrospray ionisation)-MS(mass spectrometry) has been
László Dux
3
modified. Main modifications were a change in the buffer composition
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1 oftheHPLC,achangeinthegradientelutionprofileandtheintroduction
of a post-column splitting system. The long-term stability of the HPLC-
ESI-MS system proved to be of high importance to get reproducible
results. 1 Reference Measurement
Laboratory, Instand e.V.,
Düsseldorf, Germany Using the modified HPLC conditions stable retention times, high peak
symmetry and a good column batch-to-batch reproducibility of the
analytical results were obtained. 2 Department of Clinical
Chemistry and Laboratory The mean deviation from the target values was less than 0.7% with an
imprecision of less than 2%. Diagnostics, Heinrich-Heine-
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Albert Szent-Györgyi Zusammenfassung
Das Referenzmessverfahren zur Bestimmung von HbA1c (glykiertes Hä-
moglobin) mittels HPLC(Hochleistungsflüssigkeitschromatografie)-ESI-
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Szeged, Hungary
(Elektrospray-Ionisation)-MS(Massenspektrometrie) wurde modifiziert.
DiewesentlichenModifikationenbesteheninderÄnderungderZusam-
mensetzung des HPLC-Puffers, der Änderung des Gradientenelutions-
profils und der Einführung eines „post-column splitting“ Systems. Dar-
überhinauserwiessichdieLangzeitstabilitätdesHPLC-ESI-MSSystems
als äußerst wichtig für die Reproduzierbarkeit der Ergebnisse.
UnterVerwendungdermodifiziertenHPLCBedingungenwurdenstabile
Retentionszeiten,einehohePeaksymmetrieundeineguteReproduzier-
barkeit,auchbeiverschiedenenSäulenchargenerreicht.Eswurdeeine
Abweichung von den Zielwerten von weniger als 0,7% und eine Unprä-
zision von weniger als 2% erzielt.
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Introduction
The original IFCC (International Federation of Clinical
ChemistryandLaboratoryMedicine)referencemeasure-
ment procedure for the determination of HbA1c in human
blood has been developed by an international group of
laboratories collaborating in the “IFCC Working Group on
Standardization of HbA1c” and has been published in de-
tail [1]. The principle of measurement of the IFCC refer-
ence measurement procedure is based on the determin-
ation of the ratio of glycated and non-glycated N-terminal
hexapeptides of the β-chains of haemoglobin.
Under our conditions the original IFCC reference meas-
urementprocedureshowedalackofrobustness.Unstable
retention times between column batches and within a
measuring sequence were observed. Additionally, peak
tailing was seen, resulting in a poor reproducibility of the
results.Sincethecalibrationisbasedontime-consuming
measurements of external standards the long-term sta-
bility of the HPLC-ESI-MS system is of high importance to
get reproducible results.
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get a higher robustness of the measurement procedure
combined with a better accuracy and precision.
Materials and methods
Chemicals
Trifluoroacetic acid (25% solution in water) and acetoni-
trile(LiChrosolv)werepurchasedfromMerck,Darmstadt,
Germany. For proteolysis endoproteinase Glu-C (sequen-
cing grade, EC 3.4.21.19) was obtained from Roche
Diagnostics, Penzberg, Germany. Synthetic glycated
hexapeptide (1-Deoxyfructosyl-VHLTPE) was obtained
from Orpegen Pharma, Heidelberg, Germany.
Water was preparedusingthe purificationsystem Direct-
Q™ 5 (Millipore GmbH, Eschborn, Germany). The Zorbax
SB-CN column (2.1 x 150 mm, 5 µm) was obtained from
Agilent Technologies Deutschland GmbH, Böblingen,
Germany.
Apparatus
The HPLC system used was from Shimadzu (Duisburg,
Germany) and consisted of a SCL-10A system controller,
three LC-10ADvp pumps (A, B, C), a DGU-14A degasser,
a SIL-10AD autoinjector, a CTU-10AS column oven, and
a FCU-12A Flow Switch (rotary valve).
The mass spectrometer was an API 4000 equipped with
a TurboV™ ESI source with Turboion Spray™ probe from
Applied Biosystems (MDS-Sciex, Darmstadt, Germany).
Sample preparation and calculation
ThesampleswerepreparedaccordingtotheoriginalIFCC
reference measurement procedure [1].
Briefly, the method has three steps:
In the first step the whole blood sample is haemolysed.
Inthesecondstepaproteolyticcleavageofhaemoglobin
is performed. For proteolysis the haemolysed sample is
treated with endoproteinase Glu-C to cleave the poly-
peptidechainattheGlu-Glupositions.Duringtheenzymat-
ic cleavage of the β-chains of haemoglobin glycated and
non-glycated β-N-terminal hexapeptides are generated.
In the third step the hexapeptides are separated chro-
matographically and measured by LC-ESI-MS.
Quantification is performed by external calibration. For
calibration six mixtures of chromatographically purified
HbA1c and HbA0 (“calibrators” obtained from the IFCC
Working Group on Standardization of HbA1c) are digested
(together with the controls and EQAS (External Quality
AssessmentSchemes)samples)andanalysedbyLC-ESI-
MS. For the calibration curve the ratios of the concentra-
tions of HbA1c and HbA0 in the calibrators are plotted
against the peak area ratios of their β-N-terminal
hexapeptides.ThepercentageofHbA1cinthesamplecan
becalculatedfromtheregressioncurve.Accordingtothe
protocol of the IFCC reference measurement procedure
for HbA1c the calibrators are measured before and again
after the controls and EQAS samples. The total analytical
timeformeasurement,includingcalibrators,controlsand
EQAS samples is about 24 h. More information can be
obtained at http://www.ifcchba1c.net/.
HPLC-MS measurement conditions
The modified conditions for determination of HbA1c were
as follows:
Elution was performed on Zorbax SB-CN column (2.1 x
150 mm, 5 µm) using a binary gradient consisting of
eluentA(pump A):0.07% v/v trifluoroaceticacidinwater
and eluent B (pump B): 0.07% v/v trifluoroacetic acid in
acetonitrile. The flow rate was 350 µl/min. The column
temperature was 50°C. In order to avoid contamination
of the ESI source a switching valve system (rotary valve
A) was introduced. At position 0 of rotary valve A the elu-
ate passed into the ESI source. At position 1 the eluate
was discarded, during which the ESI source is supplied
with 50% acetonitrile (eluent C), delivered by pump C
(auxiliarypump),withaflowrateof350µl/min.Theinjec-
tion volume was 3 µl.
The HPLC conditions for determination of HbA1c, the set-
tings of the API 4000 mass spectrometer and the detec-
tion masses in the Q1 multiple ion mode for the β-N-ter-
minalhexapeptidesofHbA1candHbA0areshowninTables
1 , 2, and 3. (The abbreviations for settings are specific
to the API 4000 software used to control the system).
The MS detection of the hexapeptides was performed at
high resolution in the positive ion mode. Setting of the
needle position was: horizontal axis 5 mm and vertical
axis 10 mm.
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Table 2: Settings of the API 4000 mass spectrometer for Q1 multiple ion mode
Table 3: Detection masses in Q1 multiple ion mode for the doubly charged β-N-terminal hexapeptides of HbA1c and HbA0
Results
Inlong-termevaluationusingtheoriginalchromatographic
conditionsdescribedintheIFCCreferencemeasurement
procedure [1], [2], peak tailing (see Figure 1), irregular
peak profiles and instability of the retention time in the
chromatographic separation were observed resulting in
a poor robustness of the method. Additionally, a lack of
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Kaiser et al.: Modification of the IFCC reference measurement procedure ...Figure 1: HPLC-ESI-MS chromatogram of a digested haemolysate sample obtained by using the original chromatographic
conditions of the IFCC reference measurement procedure with column-batch 1.
Overlaidgraphs:masstraceofthedoublychargedβ-N-terminalhexapeptideofHbA0(m/z348.3amu,blueline)andHbA1c(m/z
429.3 amu, red line).
reproducibility of column selectivity from batch-to-batch
was detected (see Figures 1 and 2).
TheIFCCreferencemeasurementprocedurewasmodified
in several steps. A change in the LC buffer composition,
a change in the LC gradient elution profile and a post
column splitting system were introduced. To prevent
clogging of the ESI-probe an auxiliary pump was added,
which supplies the ESI source with eluent C, when
switching the ESI source out of the HPLC flow during
column rinsing. The original HPLC conditions described
in the IFCC reference measurement procedure and the
modified conditions are demonstrated in Table 4.
One of the main modifications is the increase of the TFA
(trifluoroaceticacid)concentrationinbothelutionbuffers
(A and B) to 0.07%. Furthermore, a steeper gradient was
introduced, followed by an isocratic phase at a higher
acetonitrile concentration (10% elution buffer B).
In contrast to the original IFCC conditions the modified
separation conditions give excellent peak symmetry,
stableretentiontimesandagoodcolumnbatch-to-batch
reproducibility (Figures 3 and 4). The β-N-terminal
hexapeptides elute within the isocratic phase of the
gradient, independent of the column batches. The modi-
fied method avoids peak tailing and shifts of retention
times in problematic column batches (compare Figures
1 and 3).
Undesirablein-sourcefragmentationmayoccurbypartial
cleavage of the sugar residue from the glycated β-N-ter-
minal hexapeptide leading to incorrect analytical results
for the percentage HbA1c. To investigate whether under
theselectedconditionsin-sourcefragmentationisgener-
ated, a high concentration of synthetic glycated
hexapeptide, identical to the glycated β-N-terminal
hexapeptide of HbA1c, was measured under the modified
HPLC conditions. As demonstrated in Figure 5 no signal
is detected on the mass trace of the non-glycated β-N-
terminalhexapeptide(m/z348.3amu),sothatin-source
fragmentationcanbeexcludedundertheselectedcondi-
tions.
Evaluation of the new method was performed using cer-
tified reference materials supplied by the IFCC network
for HbA1c standardization.
The analytical imprecision was assessed by repeated
measurements(n=39)ofonehaemolysatesampleunder
theoriginalIFCCconditionsincomparisontoourmodified
conditions (Table 5).
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Kaiser et al.: Modification of the IFCC reference measurement procedure ...Figure 2: HPLC-ESI-MS chromatogram of a digested haemolysate sample obtained by using the original chromatographic
conditions of the IFCC reference measurement procedure with column-batch 2.
Overlaidgraphs:masstraceofthedoublychargedβ-N-terminalhexapeptideofHbA0(m/z348.3amu,blueline)andHbA1c(m/z
429.3 amu, red line).
Table 4: HPLC conditions for determination of HbA1c by HPLC-ESI-MS according to the original IFCC reference measurement
procedure and the modified method
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Kaiser et al.: Modification of the IFCC reference measurement procedure ...Figure 3: HPLC-ESI-MS chromatogram of a digested haemolysate sample obtained by using the optimized chromatographic
conditions with column-batch 1.
Overlaidgraphs:masstraceofthedoublychargedβ-N-terminalhexapeptideofHbA0(m/z348.3amu,blueline)andHbA1c(m/z
429.3 amu, red line).
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Kaiser et al.: Modification of the IFCC reference measurement procedure ...Figure 4: HPLC-ESI-MS chromatogram of a digested haemolysate sample obtained by using the optimized chromatographic
conditions with column-batch 2.
Overlaidgraphs:masstraceofthedoublychargedβ-N-terminalhexapeptideofHbA0(m/z348.3amu,blueline)andHbA1c(m/z
429.3 amu, red line).
Substantial improvement of precision was achieved by
the HPLC modifications. The CV (coefficient of variation)
was lowered by a factor of more than 2.
Foraccuracycontrolhaemolysatesampleswithassigned
targetvaluessetbytheIFCCNetworkforHbA1cStandard-
ization were used. A clear enhancement of accuracy was
obtained by the modifications as demonstrated for the
experiment in Table 6.
The mean deviation of the values from the IFCC target
values measured in several campaigns was less than
0.7% with an imprecision of less than 2%.
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Kaiser et al.: Modification of the IFCC reference measurement procedure ...Figure 5: HPLC-ESI-MS chromatogram of a synthetic glycated hexapeptide identical to the glycated β-N-terminal hexapeptide
of HbA1c.
Overlaidgraphs:masstraceofthedoublychargedβ-N-terminalhexapeptideofHbA0(m/z348.3amu,blueline)andHbA1c(m/z
429.3 amu, red line).
Table 5: Imprecision of measurements obtained by repeated injections of a digested haemolysate sample using the original
HPLC conditions of the IFCC reference measurement procedure and the modified method
Table6:InaccuracyofmeasurementsobtainedbyinjectionsofdigestedhaemolysatesamplesusingtheoriginalHPLCconditions
of the IFCC reference measurement procedure and the optimized method
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In the IFCC reference measurement procedure for deter-
mination of HbA1c quantification is based on calibration
with external standards consisting of defined concentra-
tionsofchromatographicallypurifiedHbA0andHbA1c. For
this kind of calibration an excellent long-term stability of
the HPLC-ESI-MS system is important. According to the
protocol of the IFCC reference measurement procedure
for determination of HbA1c [1], the results for the EQAS
samples and the controls are calculated by calibration in
the beginningandat the endof the measuringsequence
requiring an analytical period of 24 h.
Stablepeakarearatiosarerequiredfortheaccuracyand
precision of the results, and the repeated calibration
curvesinonemeasuringsequenceshouldbecongruent.
Several ESI-MS systems with different technical designs
of the electrospray ionisation source were tested. The
necessary long-term stability for this special application
could not be accomplished with all ESI-MS systems. The
API4000showedhighsystemstability,resultinginrepro-
ducible calibration curves within a measuring sequence.
The precision of HbA1c measurements with HPLC-ESI-MS
is strongly dependent on the stability of the retention
time. The stability of the retention times and the peak
form were improved by increasing the concentration of
TFA in the elution buffer. The best results were obtained
by adding 0.07% TFA to the eluents. Using this TFA con-
centration peak tailing was substantially diminished,
without introducing ion suppressioneffects. By changing
thegradientelutionprofiletheβ-N-terminalhexapeptides
of HbA1c and HbA0 both eluted in the plateau phase at
10% eluent B, independent of the column batch used.
The ionisation of the glycated and non-glycated β-N-ter-
minalhexapeptidesis influencedby the concentrationof
TFA and acetonitrile to different extent. Therefore, best
reproducibilityofthepeakarearatiosisobtainedbypeak
elution under isocratic conditions due to stable electros-
pray ionisation. Narrow symmetric peaks were obtained.
Since the use of the synthetic glycated hexapeptide
demonstrated the absence of in-source fragmentation,
it was not necessary to separate the two analytes com-
pletely.
Togetreproducibleresultsextensionoftheruntimefrom
23 min to 28 min was required in order to equilibrate the
cyano-columnwiththeaqueousphase(eluentA).Column
selectivity and separation characteristics were reprodu-
cible from batch-to-batch under the modified HPLC con-
ditions.
Another important aspect is the prevention of ESI-MS
system overloading. The concentration of HbA1c in
samples, which are preparedaccording to the IFCC refer-
encemeasurementprocedure,istoohighfordirectinjec-
tion into the LC-MS system, when using the API 4000.
Injecting the haemolysates at volumes as low as 1 µl the
linearity of the calibration curve was not satisfactory.
Therefore, a post column flow splitting system was in-
stalled.
Reference measurement procedures are well defined in
International Standards (ISO 15193) [3]. Their use for
setting target values in External Quality Assessment
Schemes (EQAS) is preferred and explained in the
European Standard EN 14136:2004 [4]. In Germany the
mandatory “Guideline of the Federal Medical Council for
Quality Assurance of Quantitative Analyses in Laboratory
Medicine” requires reference measurement procedures
for setting target values for HbA1c in the national EQAS.
The acceptability criteria for reference measurement
proceduresforimprecisionandinaccuracyshouldbe1/3
to those of routine methods in the German Guideline [5].
Thus, the reference measurement procedure for HbA1c
should have less than 2.3% imprecision and inaccuracy.
In this study the imprecision of repeated measurements
wasimprovedfrommorethan3%to1.35%.Moreimport-
ant, the target values of controls, supplied by the IFCC
network were met within 2.5% with higher reliability.
The accuracy of the modified LC-ESI-MS method was as-
certained in our laboratory by comparing the results with
those obtained by the IFCC reference measurement pro-
cedure for HbA1c by HPLC/capillary electrophoresis [1]
and by repeated successful participation in international
intercomparison studies of the IFCC Network for Stand-
ardization of HbA1c.
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